Reducing the incidence of 131I-induced sialadenitis: The role of pilocarpine

Journal of Nuclear Medicine

Volumn 49, Issue 4, 2008, Pages 546-549

  Silberstein, Edward B ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

131I; Pilocarpine; Radiation sialadenitis; Serotonin receptor antagonist

Indexed keywords

DEXAMETHASONE; DOLASETRON MESILATE; IODINE 131; PILOCARPINE; SUGAR; INDOLE DERIVATIVE; QUINOLIZINE DERIVATIVE; RADIOACTIVE IODINE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSGEUSIA; FEMALE; FOLLICULAR CARCINOMA; HUMAN; LIQUID; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MORBIDITY; MOUTH; NIGHT; OUTPATIENT DEPARTMENT; PAIN; PAPILLARY CARCINOMA; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALIVA; SEX; SIALOADENITIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMATITIS; SYMPTOM; TELEPHONE; THYROID CANCER; THYROID CARCINOMA; WAKEFULNESS; XEROSTOMIA; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THYROID TUMOR;

ADULT; DEXAMETHASONE; FEMALE; HUMANS; INDOLES; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PILOCARPINE; PROSPECTIVE STUDIES; QUINOLIZINES; SIALADENITIS; SINGLE-BLIND METHOD; THYROID NEOPLASMS;

EID: 42049084199     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.049411     Document Type: Article

References (19)

1. Chow SM. Side effects of high-dose radioactive iodine for ablation or treatment of differentiated thyroid carcinoma. J Hong Kong Coll Radiol. 2005;8:127-135.
2. Goolden AWG, Mallard JR. Farran HEA Radiation sialitis following radioiodine therapy. Br J Radiol. 1957;30:210-212.
3. van Nostrand D, Neutze J, Atkins F. Side effects of "rational dose'' iodine-131 therapy for metastatic well-differentiated thyroid carcinoma. J Nucl Med. 1986; 27:1519-1527.
4. Mandel SJ, Mandel L. Radioactive iodine and the salivary glands. Thyroid. 2003;13:265-271.
5. Alexander C, Bader JB, Schaefer A, et al. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. J Nucl Med. 1998; 39:1551-1554.
6. Walter MA, Turtschi CP, Schindler C, et al. The dental safety profile of highdose radioiodine therapy for thyroid cancer: long term results of a longitudinal cohort study. J Nucl Med. 2007;48:1620-1625.
7. Kita T, Yokoyama K, Higuchi T, et al. Multifactorial analysis on the short-term side effects occurring within 96 hours after radioiodine-131 therapy for differentiated thyroid carcinoma. Ann Nucl Med. 2004;18:345-349.
8. Turner JT, Sullivan DM, Rovira J, et al. A regulatory role in mammalian salivary glands for 5-hydroxytryptamine receptors coupled to increased cyclic AMP production. J Dent Res. 1996;75:935-941.
9. Eisbruch A. Reducing xerostomia by IMRT: what may, and many not, be achieved? J Clin Oncol. 2007;25:4863-4864.
10. Meirovitz A, Murdoch-Kinch CA, Schipper M, et al. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;66:445-453.
11. Albrecht HH, Creutzig H. Salivary gland scintigraphy after radio-iodine therapy: functional scintigraphy of the salivary gland after high dose radio-iodine therapy [in German]. Rofo. 1976;125:546-551.
12. Solans R, Bosch JA, Galofré P, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med. 2001;42:738-743.
13. Raza H, Khan AU, Hameed A, et al. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy. Nucl Med Commun. 2006;27:495-499.
14. Caglar M, Tuncel M, Alpar R. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med. 2002;27:767-771.
15. Allweiss P, Braunstein GD, Katz A, et al. Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication. J Nucl Med. 1984;25:755-758.
16. Bohuslavizki KH, Klutmann S, Brenner W, et al. Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double blind placebo-controlled study. J Clin Oncol. 1998;16:3542-3549.
17. Nakada K, Ishibashi T, Takei T, et al. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med. 2005;46:261-266.
18. Physicians' Desk Reference. 58th ed. Montvale, NJ: Thompson PDR; 2004: 1911-1912.
19. Nakada K. Re: does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? [reply to letter]. J Nucl Med. 2005;46:2118-2119.